Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease

American Heart Journal

Volumn 142, Issue 5, 2001, Pages 872-880

  Henry, Timothy D ^a   Rocha Singh, Krishna ^b   Isner, Jeffrey M ^c   Kereiakes, Dean J ^d   Giordano, Frank J ^e   Simons, Michael ^f   Losordo, Douglas W ^c   Hendel, Robert C ^g   Bonow, Robert O ^g   Eppler, Stephen M ^h   Zioncheck, Thomas F ^h   Holmgren, Eric B ^h   McCluskey, Edward R ^h  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b Prairie Cardiovascular Consultants Ltd   (United States)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

^d CHRIST HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g Northwestern Medical Center   (United States)

^h GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEMODYNAMIC MONITORING; HUMAN; HYPOTENSION; LEFT CORONARY ARTERY; MALE; MAXIMUM TOLERATED DOSE; PRIORITY JOURNAL; RIGHT CORONARY ARTERY; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0034750066     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.118471     Document Type: Article

References (31)

1. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction
2. Recent insights into coronary collateral circulation
3. Molecular mechanisms of coronary collateral vessel growth
4. The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size
5. The biology of vascular endothelial growth factor
6. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
7. Vascular endothelial growth factor administration in chronic myocardial ischemia
8. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis
9. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia
10. VEGF administration in chronic myocardial ischemia in pigs
11. Review of preclinical results with vascular endothelial growth factors for therapeutic angiogenesis
12. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease
13. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial
14. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
15. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease
16. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease
17. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a phase I open label dose escalation study
18. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: Evidence for a dose-dependent effect
19. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
20. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects
21. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo
22. Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection
23. Can we really grow new blood vessels?
24. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
25. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension: Evidence for a maintenance role in quiescent adult endothelium
26. Hemodynamic effects of intracoronary VEGF delivery: Evidence of tachyphylaxis and NO dependence of response
27. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy
28. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin
29. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
30. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein e-deficient mice
31. Placebo effect of nitrate monotherapy for myocardial ischemia